McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity [Seeking Alpha]
McKesson Corporation (MCK)
Last mckesson corporation earnings: 2/4 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.mckesson.com
Company Research
Source: Seeking Alpha
healthcare services platform focused on Oncology & Multispecialty and Prescription Technology Solutions. MCK's upgraded long-term adjusted EPS growth target of 13%-16%, aggressive capital returns, and strategic realignment support a bullish outlook and potential for significant stock price appreciation by FY2030. Key risks include regulatory pressure on U.S. drug pricing, opioid litigation overhangs, execution risks in acquisitions and divestitures, and high customer concentration, which may cause volatility or corrections. Any market-driven pullbacks are viewed as long-term accumulation opportunities, provided MCK continues to deliver on financial targets, segment growth, and capital allocation milestones. JHVEPhoto/iStock Editorial via Getty Images I put a ‘Buy' label on McKesson Corporation's ( NYSE: MCK ) stock after observing its transformation into a higher-growth + higher-margin healthcare-services-platform. My thesis is mostly focused on McKesson's strategic realignm
Show less
Read more
Impact Snapshot
Event Time:
MCK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCK alerts
High impacting McKesson Corporation news events
Weekly update
A roundup of the hottest topics
MCK
News
- McKesson (NYSE:MCK) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- McKesson (NYSE:MCK) had its "buy (a-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Mazdutide 9 mg Achieves Up to 20.1% Weight Loss in Chinese Adults with Obesity, GLORY-2 Study Meets Primary and All Key Secondary Endpoints [Yahoo! Finance]Yahoo! Finance
- McKesson Corporation (MCK) Strong Quarter Spurs Analyst Confidence [Yahoo! Finance]Yahoo! Finance
- McKesson (NYSE:MCK) had its "buy (b+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
MCK
Earnings
- 11/5/25 - Beat
MCK
Sec Filings
- 11/17/25 - Form 25-NSE
- 11/10/25 - Form 4
- 11/6/25 - Form 10-Q
- MCK's page on the SEC website